Aleafia Health Inc. (ALEAF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Aleafia Health Inc. (ALEAF) with AI Score 38/100 (Weak). Aleafia Health Inc. is a Canadian cannabis company focused on health and wellness products, operating both domestically and internationally. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Aleafia Health Inc. (ALEAF) Healthcare & Pipeline Overview
Aleafia Health Inc. is a Canadian cannabis company producing cannabis oils, capsules, edibles, and dried flower, operating a virtual network of medical cannabis clinics. With a focus on health and wellness, Aleafia distributes its products under various brands in a competitive market, facing challenges in profitability and market share.
Investment Thesis
Aleafia Health Inc. presents a speculative investment opportunity in the cannabis sector. The company's diverse product portfolio and clinic network offer potential revenue streams, but its negative profit margin of -98.8% raises concerns about financial sustainability. The high beta of 2.08 indicates significant volatility relative to the market. Growth catalysts include expansion of its product lines and increased market penetration in Canada and internationally. However, the company faces risks related to regulatory changes, competition, and achieving profitability. Investors should carefully consider these factors before investing.
Based on FMP financials and quantitative analysis
Key Highlights
- Aleafia Health Inc. operates in the cannabis health and wellness sector, offering a diverse range of products including oils, capsules, edibles, and dried flower.
- The company owns and operates a virtual network of medical cannabis clinics, providing consultations and treatment plans to patients.
- Aleafia Health's product portfolio is marketed under various brands, including Divvy, Sunday Market, Bogart's Kitchen, and Emblem.
- The company's gross margin is 14.0%, indicating a relatively low level of profitability.
- Aleafia Health's market capitalization is $0.00B, reflecting its small size and potential for growth or volatility.
Competitors & Peers
Strengths
- Diverse product portfolio including oils, edibles, and dried flower.
- Virtual network of medical cannabis clinics.
- Established brands such as Divvy and Emblem.
- International presence.
Weaknesses
- Negative profit margin of -98.8%.
- High beta of 2.08 indicating high volatility.
- Limited market capitalization of $0.00B.
- Reliance on evolving cannabis regulations.
Catalysts
- Upcoming: Potential regulatory changes in cannabis laws could expand market access.
- Ongoing: Expansion of the company's product lines to include new cannabis-based products.
- Ongoing: Increased market penetration in Canada and internationally through strategic partnerships.
- Ongoing: Development of proprietary cannabis strains with unique characteristics.
Risks
- Ongoing: Increasing competition from other cannabis producers in a saturated market.
- Potential: Regulatory changes impacting cannabis production and sales could negatively affect revenue.
- Potential: Fluctuations in cannabis prices could impact profitability.
- Potential: Product recalls or safety concerns could damage the company's reputation.
- Ongoing: The company's negative profit margin of -98.8% raises concerns about financial sustainability.
Growth Opportunities
- Expansion of Product Lines: Aleafia Health can expand its product lines to include new and innovative cannabis-based products. The market for cannabis edibles, beverages, and topicals is growing rapidly, offering opportunities for the company to capture additional market share. The timeline for product development and launch is approximately 6-12 months, and the market size for these products is estimated to be in the hundreds of millions of dollars.
- Increased Market Penetration: Aleafia Health can increase its market penetration in Canada and internationally by expanding its distribution network and marketing efforts. The company can target specific customer segments, such as medical cannabis patients and recreational users, with tailored products and services. The timeline for market expansion is approximately 12-24 months, and the market size is estimated to be in the billions of dollars.
- Strategic Partnerships: Aleafia Health can form strategic partnerships with other companies in the cannabis industry, such as retailers, distributors, and technology providers. These partnerships can help the company expand its reach, improve its efficiency, and access new technologies. The timeline for forming strategic partnerships is approximately 6-12 months, and the potential benefits are significant.
- Development of Proprietary Strains: Aleafia Health can develop proprietary strains of cannabis with unique characteristics and benefits. These strains can be used to create differentiated products that appeal to specific customer segments. The timeline for developing proprietary strains is approximately 12-24 months, and the potential for increased profitability is significant.
- Expansion of Clinic Network: Aleafia Health can expand its virtual network of medical cannabis clinics to reach more patients and provide access to cannabis-based treatments. The company can also offer new services, such as telemedicine consultations and personalized treatment plans. The timeline for expanding the clinic network is approximately 6-12 months, and the potential for increased revenue is significant.
Opportunities
- Expansion of product lines to include new cannabis-based products.
- Increased market penetration in Canada and internationally.
- Strategic partnerships with other companies in the cannabis industry.
- Development of proprietary cannabis strains.
Threats
- Increasing competition from other cannabis producers.
- Regulatory changes impacting cannabis production and sales.
- Fluctuations in cannabis prices.
- Potential for product recalls or safety concerns.
Competitive Advantages
- Brand recognition through established brands like Divvy and Emblem.
- Virtual network of medical cannabis clinics provides direct access to patients.
- Diverse product portfolio caters to various consumer preferences.
- Proprietary strains and formulations offer unique product offerings.
About ALEAF
Aleafia Health Inc. is a cannabis health and wellness company operating in Canada and internationally. The company was founded with the vision of providing cannabis-based solutions for medical and recreational use. Aleafia's product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, vape cartridges, bath bombs, soft gels, hang dried, hand trimmed, long cured, and small batch dried flower, and concentrates. These products are marketed under brands like Divvy, Sunday Market, Bogart's Kitchen, Noon & Night, Nith & Grand, Kin Slips, and Emblem. Beyond product manufacturing, Aleafia Health also operates a virtual network of medical cannabis clinics staffed by physicians and nurse practitioners, offering consultations and treatment plans to patients. Additionally, the company runs education centers aimed at increasing awareness and understanding of cannabis and its potential benefits. Aleafia Health is headquartered in Concord, Canada, and serves both domestic and international markets. The company faces competition from other cannabis producers and healthcare providers in the rapidly evolving cannabis industry.
What They Do
- Cultivates and processes cannabis.
- Manufactures cannabis oils, capsules, and edibles.
- Produces cannabis-infused sublingual strips and vape cartridges.
- Offers bath bombs and soft gels.
- Sells hang dried, hand trimmed, long cured, and small batch dried flower.
- Produces cannabis concentrates.
- Operates a virtual network of medical cannabis clinics.
- Runs education centers.
Business Model
- Cultivation and processing of cannabis.
- Manufacturing and sale of cannabis products.
- Operation of medical cannabis clinics.
- Provision of cannabis education services.
Industry Context
Aleafia Health operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is becoming increasingly competitive, with numerous companies vying for market share. Aleafia Health competes with other cannabis producers and healthcare providers in Canada and internationally. The industry is subject to evolving regulations, which can impact the company's operations and profitability. Trends include increasing demand for cannabis-based health and wellness products, as well as the growing acceptance of cannabis for medical and recreational use.
Key Customers
- Medical cannabis patients seeking treatment.
- Recreational cannabis users.
- Consumers of cannabis-based health and wellness products.
- Individuals seeking cannabis education.
Financials
Chart & Info
Aleafia Health Inc. (ALEAF) stock price: Price data unavailable
Latest News
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · Aug 5, 2025
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · Jun 10, 2025
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALEAF.
Price Targets
Wall Street price target analysis for ALEAF.
MoonshotScore
What does this score mean?
The MoonshotScore rates ALEAF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
Leadership: Patricia Symmes
CEO
Patricia Symmes is the CEO of Aleafia Health Inc. Her background includes experience in managing teams and overseeing operations within the healthcare sector. She has demonstrated leadership in guiding the company through various stages of growth and development. Her expertise lies in strategic planning, operational efficiency, and market expansion. She is responsible for driving the company's vision and ensuring its long-term success in the competitive cannabis industry.
Track Record: Under Patricia Symmes' leadership, Aleafia Health has focused on expanding its product portfolio and strengthening its presence in the Canadian cannabis market. Key milestones include the launch of new product lines and the expansion of the company's virtual clinic network. She has also overseen efforts to improve operational efficiency and reduce costs. Her strategic decisions have aimed to position Aleafia Health for long-term growth and profitability.
ALEAF OTC Market Information
OTC Other, also known as the Pink Market, represents the lowest tier of the OTC market. Companies in this tier may not meet minimum financial standards and have limited reporting requirements. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies often have less stringent listing requirements, resulting in higher risk and volatility for investors. Information availability may be limited, and trading volumes can be thin, making it difficult to execute large trades without significantly impacting the price.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure requirements.
- Potential for fraud or manipulation.
- Thin trading volume and wide bid-ask spreads.
- Higher price volatility compared to exchange-listed stocks.
- Risk of delisting or suspension of trading.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Evaluate the company's liquidity and trading volume.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Operation of a virtual network of medical cannabis clinics.
- Established brands such as Divvy and Emblem.
- International presence.
- Presence of a CEO and management team.
Aleafia Health Inc. Stock: Key Questions Answered
What does Aleafia Health Inc. do?
Aleafia Health Inc. operates as a cannabis health and wellness company, focusing on the cultivation, processing, and distribution of cannabis products. The company's product portfolio includes cannabis oils, capsules, edibles, and dried flower, marketed under various brands. Additionally, Aleafia Health operates a virtual network of medical cannabis clinics, providing consultations and treatment plans to patients. The company also runs education centers to increase awareness and understanding of cannabis and its potential benefits, serving both medical and recreational markets.
What do analysts say about ALEAF stock?
As of 2026-03-17, formal analyst ratings for Aleafia Health Inc. (ALEAF) are limited due to its OTC listing and smaller market capitalization. Key valuation metrics, such as the negative P/E ratio, reflect the company's current lack of profitability. Growth considerations include the expansion of its product lines and market penetration, but these are balanced against risks related to competition and regulatory changes. Investors should conduct thorough due diligence and consider their own risk tolerance before investing.
What are the main risks for ALEAF?
Aleafia Health Inc. faces several risks, including intense competition in the cannabis market, which can pressure prices and market share. Regulatory changes in cannabis laws could impact the company's operations and profitability. Fluctuations in cannabis prices can affect revenue and margins. Product recalls or safety concerns could damage the company's reputation and lead to legal liabilities. The company's current financial performance, characterized by a negative profit margin, also poses a significant risk to its long-term sustainability.
How does Aleafia Health Inc. navigate regulatory approval processes?
Aleafia Health Inc. operates in a highly regulated industry and must comply with various regulations related to cannabis production, distribution, and sale. The company navigates regulatory approval processes by maintaining a dedicated compliance team that monitors changes in regulations and ensures adherence to all applicable laws. Aleafia Health also works closely with regulatory agencies to obtain necessary licenses and permits. The company's compliance strategy focuses on transparency, accountability, and continuous improvement to mitigate regulatory risks and maintain its operational licenses.
How does Aleafia Health Inc. differentiate its cannabis products in a competitive market?
Aleafia Health Inc. differentiates its cannabis products through a combination of brand building, product innovation, and quality control. The company markets its products under various brands, each targeting specific consumer segments. Aleafia Health also invests in research and development to create new and innovative cannabis-based products with unique characteristics and benefits. The company maintains strict quality control standards throughout its production process to ensure the safety and efficacy of its products. This multifaceted approach allows Aleafia Health to stand out in a competitive market and attract loyal customers.
What are the key factors to evaluate for ALEAF?
Aleafia Health Inc. (ALEAF) currently holds an AI score of 38/100, indicating low score. Key strength: Diverse product portfolio including oils, edibles, and dried flower.. Primary risk to monitor: Ongoing: Increasing competition from other cannabis producers in a saturated market.. This is not financial advice.
How frequently does ALEAF data refresh on this page?
ALEAF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ALEAF's recent stock price performance?
Recent price movement in Aleafia Health Inc. (ALEAF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product portfolio including oils, edibles, and dried flower.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data may be limited due to the company's OTC listing.
- AI analysis pending for ALEAF.